Skip to main content
SpringerLink
Log in

Sentinel Lymph Node Biopsy in Prostatic Cancer

  • Chapter
Radioguided Surgery

  • 744 Accesses

Abstract

The identification of lymph drainage has significant clinical importance for tumor spread in prostatic cancer. Pelvic lymph node metastases indicate a poor prognosis for patients with clinically localized prostate cancer. The prognosis depends on nodal cancer volume (1), extracapsular extension (2), and the number of prostatic nodes affected (3). It is not clear whether the more valuable prognostic factor is the diameter of the largest metastases, or the total number of positive lymph nodes (4).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cheng L, Pisansky TM, Ramnani DM, et al. Extranodal extension in lymph node-positive prostate cancer. Mod Pathol. 2000;13:113–118.

    Article  CAS  PubMed  Google Scholar 

  2. Griebling TL, Ozkutlu D, See WA, et al. Prognostic implications of extracapsular extension of lymph node metastases in prostate cancer. Mod Pathol. 1997;10:804–809.

    CAS  PubMed  Google Scholar 

  3. Cheng L, Zincke H, Blute ML, et al. Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer. 2001;91:66–73.

    Article  CAS  PubMed  Google Scholar 

  4. Cheng L, Bergstralh EJ, Cheville JC, et al. Cancer volume of lymph node metastasis predicts progression in prostate cancer. Am J Surg Pathol. 1998;22:1491–1500.

    Article  CAS  PubMed  Google Scholar 

  5. Aus G, Abbou CC, Pacik D, et al. EAU guidelines on prostate cancer. Eur Urol. 2001;40:97–101.

    Article  CAS  PubMed  Google Scholar 

  6. Bader P, Burkhard FC, Markwalder R, et al. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol. 2003;169:849–854.

    Article  PubMed  Google Scholar 

  7. Heidenreich A, Ohlmann CH, Polyakov S. Anatomical extent of pelvic lymphadenectomy in bladder and prostate cancer. Eur Urol. 2005;4(suppl):15–24.

    Google Scholar 

  8. Messing EM, Manola J, Sarosdy M, et al. Immediate hormonal therapy versus observation after radical prostatectomy and pelvic lymphadenectomy for node positive prostate cancer: at 10 years results of EST3886. J Clin Oncol. 2004;22:abstract 4570.

    Google Scholar 

  9. Parker CC, Husband J, Dearnaley DP. Lymph node staging in clinically localized prostate cancer. Prostate Cancer Prostatic Dis. 1999;2:191–199.

    Article  PubMed  Google Scholar 

  10. Harzmann R, Bichler KH. Stellenwert der Lymphangiographie bei Tumoren der ableitenden Harnwege und des männlichen Genitale. Med Klin. 1977;72:183–197.

    CAS  PubMed  Google Scholar 

  11. Tigueret R, Gheiler EL, Tefilli MV, et al. Lymph node size does not correlate with the presence of prostate cancer metastases. Urology. 1999;53:367–371.

    Article  Google Scholar 

  12. Wolf J, Cher M, Dall’Era M, et al. The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy. J Urol. 1995;153:993–999.

    Article  PubMed  Google Scholar 

  13. Scheidler J, Hricak H, Yu KY, et al. Radiological evaluation of lymph node metastases in patients with cervical cancer: a meta-analysis. JAMA. 1997;278:1096–1101.

    Article  CAS  PubMed  Google Scholar 

  14. Van Poppel H, Ameye F, Oyen R, et al. Accuracy of combined computerized tomography and fine needle aspiration cytology in lymph node staging of localized prostatic carcinoma. J Urol. 1994;151:1310–1314.

    PubMed  Google Scholar 

  15. Barentsz JO, Jager GJ, van Vierzen PB, et al. Staging urinary bladder cancer after transurethral biopsy: value of fast dynamic contrast-enhanced MR imaging. Radiology. 1996;201:185–193.

    CAS  PubMed  Google Scholar 

  16. Harisinghani MG, Saini S, Slater GJ, et al. MR imaging of pelvic lymph nodes in primary pelvic carcinoma with ultrasmall superparamagnetic iron oxide (Combidex): preliminary observations. J Magn Reson Imaging. 1997;7:161–167.

    Article  CAS  PubMed  Google Scholar 

  17. Babaian RJ, Sayer J, Podoleff DA, et al. Radioimmunoscintigraphy of pelvic lymph nodes with 111-indium-labeled monoclonal anti-body CYT-356. J Urol. 1994;152:1952–1955.

    CAS  PubMed  Google Scholar 

  18. Hinkle GH, Burgers JK, Neal CE, et al. Multicenter radioimmunoscintigraphic evaluation of patients with prostate carcinoma using indium-111 capromab pendetide. Cancer. 1998;83:739–747.

    Article  CAS  PubMed  Google Scholar 

  19. Polascik TJ, Manyak MJ, Haseman MK, et al. Comparison of clinical staging algorithms and 111indium-capromab pendetide immunoscintigraphy in prediction of lymph node involvement in high-risk prostate carcinoma patients. Cancer. 1999;85:1586–1592.

    Article  CAS  PubMed  Google Scholar 

  20. Rigo P, Paulus BJ, Kaschten BJ, et al. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med. 1996;23:1641–1674.

    Article  CAS  PubMed  Google Scholar 

  21. Shreve PD, Grossmann HB, Gross MD, et al. Metastatic prostate cancer: initial findings of PET with 2-desoxy-2-(F-18)fluoro-D-glucose. Radiology. 1996;199:751–756.

    CAS  PubMed  Google Scholar 

  22. Heicapell R, Müller-Mattheis V, Reinhardt M. Staging of pelvic lymph nodes in neoplasm of the bladder and prostate by positron emission tomography with 2-(18F)-2-deoxy-D-glucose. Eur Urol. 1999;40:481–487.

    Google Scholar 

  23. Fricke E, Machtens S, Hofmann M, et al. Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients. Eur J Nucl Med Mol Imag. 2003;30:607–611.

    Article  CAS  Google Scholar 

  24. Sanz G, Robles JE, Gimenez M, et al. Positron emission tomography with 18fluorine-labeled deoxyglucose: utility in localized and advanced prostate cancer. Br J Urol. 1998;84:1028–1031.

    Google Scholar 

  25. Seltzer MA, Barbaric Z, Belldegrun A, et al. Comparison of helical computerized tomography, positron emission tomography and monoclonal antibody scans for evaluation of lymph node metastases in patients with prostate specific antigen relapse after treatment for localized prostate cancer. J Urol. 1999;162:1322–1328.

    Article  CAS  PubMed  Google Scholar 

  26. Sung J, Espiritu Jl, Segall GM, et al. Fluorodeoxyglucose positron emission tomography studies in the diagnostic and staging of clinically advanced prostate cancer. BJU Int. 2003;92:24–27.

    Article  CAS  PubMed  Google Scholar 

  27. Janetschek G, Langsteger W, Leeb K, et al. Detection of lymph node metastases in patients with clinically localized prostate cancer: comparison of 18 fluor cholin PET-CT with laparoscopic sentinel lymph node dissection and extended lymph node dissection. Eur Urol. 2005;3(suppl 4):68.

    Google Scholar 

  28. Bartsch Jun. G, Gottfried HW, Rinnab L, et al. Lymph node staging in prostate cancer by the use of 11C-choline-PET/CT scan imaging. Eur Urol. 2005;3(suppl 4):67.

    Google Scholar 

  29. Ackermann DA, Barry JU, Wicklund RA, et al. Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy. J Urol. 1993;150:1845–1850.

    Google Scholar 

  30. Bluestein DL, Bostwick DG, Bergstrahl EJ, et al. Eliminating the need for bilateral pelvic lymphadenectomy in selected patients with prostate cancer. J Urol. 1994;151:1315–1320.

    CAS  PubMed  Google Scholar 

  31. Dunzinger M, Sega W, Madersbacher S, et al. Predictive value of the anatomical location of ultrasound-guided systematic sextant prostate biopsies for the nodal status of patients with localized prostate cancer. Eur Urol. 1997;31:317–322.

    CAS  PubMed  Google Scholar 

  32. Wawroschek F, Harzmann R, Weckermann D. Wertigkeit der Sentinel-Lymphknotenbiopsie bei urologischen Tumoren. Urologe (A). 2005;44:630–634.

    Article  CAS  Google Scholar 

  33. Partin AW, Kattan MW, Subong ENP, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. JAMA. 1997;277:1445–1451.

    Article  CAS  PubMed  Google Scholar 

  34. Partin AW, Mangold LA, Lamm DM, et al. Contemporary update of prostate cancer staging nomograms (Partin tables) for the new millennium. Urology. 2001;58:843–848.

    Article  CAS  PubMed  Google Scholar 

  35. Cangiannos I, Karakiewicz P, Eastham JA, et al. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J Urol. 2003;170:1798–1803.

    Article  Google Scholar 

  36. Stock RG, Stone NN, Ianuzzi C. Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection: implications for patient selection in the radiotherapeutic management of prostate cancer. Int J Oncol Biol Phys. 1995;33:815–821.

    CAS  Google Scholar 

  37. Stone NN, Stock RG, Unger P. Indications for seminal vesicle biopsy and laparoscopic pelvic lymph node dissection in men with localized carcinoma of the prostate. J Urol. 1995;154:1392–1396.

    Article  CAS  PubMed  Google Scholar 

  38. Conrad S, Graefen M, Pichlmeier U, et al. Systematic sextant biopsies improve preoperative prediction of pelvic lymph node metastases in patients with clinically localized prostatic carcinoma. J Urol. 1998;159:2023–2029.

    Article  CAS  PubMed  Google Scholar 

  39. Conrad S, Graefen M, Pichlmaer U, et al. Prospective validation of an algorithm with systematic sextant biopsy to predict lymph node metastasis in patients with clinically localized prostate cancer. J Urol. 2002;167:521.

    Article  PubMed  Google Scholar 

  40. Naya Y, Babaian RJ. The predictors of pelvic lymph node metastasis at radical retropubic prostatectomy. J Urol. 2003;170:2306–2310.

    Article  PubMed  Google Scholar 

  41. Heidenreich A, Varga Z, Knobloch von R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol. 2002;167:1681–1686.

    Article  PubMed  Google Scholar 

  42. Bader P, Burkhard FC, Markwalder R, et al. Is a limited lymph node dissection an adequate staging procedure for prostate cancer? J Urol. 2002;168:514–518.

    Article  PubMed  Google Scholar 

  43. Wawroschek F, Hamm M, Weckermann D, et al. Lymph node staging in clinically localized prostate cancer. Urol Int. 2003;71:129–135.

    Article  PubMed  Google Scholar 

  44. Weckermann D, Wawroschek F, Harzmann R. Is there a need for pelvic lymph node dissection in low-risk prostate cancer patients prior to definitive local therapy? Eur Urol. 2005;47:45–51.

    Article  PubMed  Google Scholar 

  45. Catalona WJ, Smith DS. Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results. J Urol. 1998;160:2428–2434.

    Article  CAS  PubMed  Google Scholar 

  46. Kapadia K, Bochner B, Groshen S, et al. Lymph node positive disease in radical prostatectomy patients: preoperative predictors and subsequent outcome. J Urol. 1999;161(suppl):1147.

    Google Scholar 

  47. Fahlenkamp D, Müller W, Schönberger B, et al. Laparoskopische pelvine Lymphadenektomie (LPLA) in der Diagnostik des lokoregionären Prostatakarzinoms. Akt Urol. 1997;28:35–42.

    Article  Google Scholar 

  48. Winfield HN, Donovan JF, See WA, et al. Urological laparoscopic surgery. J Urol. 1991;146:941–948.

    CAS  PubMed  Google Scholar 

  49. Weingärtner K, Ramaswamy A, Bittinger A, et al. Anatomical basic for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic. J Urol. 1969;156:1969–1971.

    Article  Google Scholar 

  50. Schuessler WW, Pharand D, Vancaille TG. Laparosopic standard pelvic node dissection for carcinoma of the prostate: is it accurate? J Urol. 1993;150:898–901.

    CAS  PubMed  Google Scholar 

  51. Leitlinien zur Diagnostik von Prostatakarzinomen. Mitteilungen der DGU und des BDU. Urologe A. 1999;38:388–401.

    Article  Google Scholar 

  52. Clark T, Parekh DJ, Cookson MS, et al. Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol. 2003;169:145–148.

    Article  PubMed  Google Scholar 

  53. Paul DB, Loening SA, Narayana AS, et al. Morbidity from pelvic lymphadenectomy in staging carcinoma of the prostate. J Urol. 1983;129:1141–1144.

    CAS  PubMed  Google Scholar 

  54. Stone NN, Stock RG, Unger P. Laparoscopic pelvic lymph node dissection for prostate cancer: comparison of the extended and modified techniques. J Urol. 1997;158:1891–1894.

    Article  CAS  PubMed  Google Scholar 

  55. Winter A, Vogt C, Weckermann D, et al. Komplikationsraten verschiedener LA-Techniken beim Klinisch lokalisierten prostatakarzinom im vergleich. Der Urologe. 2005;44(Suppl 1):79.

    Google Scholar 

  56. Herrell SD, Trachtenberg J, Theodorescu D. Staging pelvic lymphadenectomy for localized carcinoma of the prostate: a comparison of 3 surgical techniques. J Urol. 1997;157:1337–1339.

    Article  CAS  PubMed  Google Scholar 

  57. Lezin MS, Cherrie R, Cattolica E. Comparison of laparoscopic and mini-laparotomy pelvic lymphadenectomy for prostate cancer staging in a community practise. Urology. 1997;49:60–64.

    Article  CAS  PubMed  Google Scholar 

  58. Paul DB, Loening SA, Narayana AS, et al. Morbidity from pelvic lymphadenectomy in staging carcinoma of the prostate. J Urol. 1983;129:1141–1144.

    CAS  PubMed  Google Scholar 

  59. McDowell GC, Johnson JW, Tenney DM, et al. Pelvic lymphadenectomy for staging clinically localized prostate cancer: indications, complications, and results in 217 cases. Urology. 1990;35:476–482.

    Article  PubMed  Google Scholar 

  60. Golimbu M, Morales P, Al Askari S, et al. Extended pelvic lymphadenectomy for prostatic cancer. J Urol. 1979;121:617–620.

    CAS  PubMed  Google Scholar 

  61. Wawroschek F, Vogt H, Wengenmair H, et al. Prostate lymphoscintigraphy and radioguided surgery for sentinel lymph node identification in prostate cancer. Urol Int. 2003;70:303–310.

    Article  PubMed  Google Scholar 

  62. Rudoni M, Sacchetti GM, Leva L, et al. Recent applications of the sentinel lymph node concept: preliminary experience in prostate cancer. Tumori. 2002;88:16–17.

    Google Scholar 

  63. Bastide C, Brenot-Rossi I, Garcia S, et al. Feasibility and value of the isotope sentinel node mapping technique in prostate cancer. Prog Urol. 2004;14:501–506.

    PubMed  Google Scholar 

  64. Sherman AI, Ter Pogossian M. Lymph node concentrative colloidal gold following interstitial injection. Cancer. 1953;6:1238–1244.

    Article  CAS  PubMed  Google Scholar 

  65. Menon M, Menon S, Strauss HW, et al. Demonstration of the existence of canine prostatic lymphatics by radioisotope technique. J Urol. 1977;118:274–277.

    CAS  PubMed  Google Scholar 

  66. Kaplan WD, Whitmore WF, Gittes RF. Visualization of canine and human prostatic lymph nodes following intraprostatic injection of technetium 99m antimony sulfide colloid. Invest Radiol. 1980;15:34–38.

    Article  CAS  PubMed  Google Scholar 

  67. Gardiner RA, Fitzpatrick JM, Constable AR, et al. Human prostatic lymphoscintigraphy: a preliminary report. Br J Urol. 1979;51:300–303.

    Article  CAS  PubMed  Google Scholar 

  68. Gardiner RA, Fitzpatrick JM, Constable AR, et al. Improved techniques in radionuclide imaging of prostatic lymph nodes. Br J Urol. 1979;51:561–564.

    Article  CAS  PubMed  Google Scholar 

  69. Zuckier LS, Finkelstein M, Kreutzer ER, et al. Technetium-99m antimony sulphide colloid lymphoscintigraphy of the prostate by direct transrectal injection. Nucl Med Commun. 1990;11:589–596.

    Article  CAS  PubMed  Google Scholar 

  70. Stone AR, Merrick MV, Chisholm GD. Prostatic lymphoscintigraphy. Br J Urol. 1979;51:556–560.

    Article  CAS  PubMed  Google Scholar 

  71. Horenblas S, Nuyten MJ, Hoefnagel CA, et al. Detection of lymph node invasion in prostatic carcinoma with iliopelvic lympho-scintigraphy. Br J Urol. 1992;69:180–182.

    Article  CAS  PubMed  Google Scholar 

  72. Wawroschek F, Vogt H, Weckermann D, et al. Radioisotope-guided pelvic lymph node dissection for prostate cancer. J Urol. 2001;166:1715–1719.

    Article  CAS  PubMed  Google Scholar 

  73. Wawroschek F, Vogt H, Wengenmair H, et al. Prostate lymphoscintigraphy and radioguided surgery for sentinel lymph node identification in prostate cancer: technique and results of the first 350 cases. Urol Int. 2003;70:303–310.

    Article  PubMed  Google Scholar 

  74. Takashima H, Egawa M, Imao T, et al. Validity of sentinel lymph node concept for patients with prostate cancer. J Urol. 2004;171:2268–2271.

    Article  PubMed  Google Scholar 

  75. Egawa M, Fukuda M, Takashima H, et al. Application of sentinel node navigation surgery to prostate cancer. Gan To Kagaku Ryoho. 2005;32:117–120.

    PubMed  Google Scholar 

  76. Wurm T, Eichhorn K, Corvin S, et al. Anatomic-functional image fusion allows intraoperative sentinel node detection in prostate cancer patients. Eur Urol. 2004;3(suppl 2):140.

    Google Scholar 

  77. Corvin S, Eichhorn K, Wurm T, et al. Radioisotope guided laparoscopic pelvic lymph node dissection—a novel technique for prostate cancer staging. Eur Urol. 2004;3(suppl 2):140.

    Google Scholar 

  78. Wawroschek F, Wengenmair H, Senekowitzsch-Schmidtke R, et al. Prostate lymphoscintigraphy for sentinel lymph node identification in canines: reproducibility, uptake, and biokinetics depending on different injection strategies. Urol Res. 2003;31:152–158.

    Article  PubMed  Google Scholar 

  79. Miltenburg DM, Miller C, Karamlou TB, et al. Meta-analysis of sentinel lymph node biopsy in breast cancer. J Surg Res. 1999;84:138–142.

    Article  CAS  PubMed  Google Scholar 

  80. Horenblas S, Jansen L, Meinhardt W, et al. Detection of occult metastasis in squamous cell carcinoma of the penis using a dynamic sentinel node procedure. J Urol. 2000;163:100–104.

    Article  CAS  PubMed  Google Scholar 

  81. Wawroschek F, Vogt H, Bachter D, et al. R. First experience of gamma probe-guided sentinel lymph node surgery in penile cancer. Urol Res. 2000;28:246–249.

    Article  CAS  PubMed  Google Scholar 

  82. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–399.

    CAS  PubMed  Google Scholar 

  83. Morton DL, Wen DR, Cochran AJ. Management of early stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy. An alternative to routine elective lymphadenectomy or watch and wait. Surg Oncol Clin N Am. 1990;1:247.

    Google Scholar 

  84. Wengenmair HE. Biokinetische und messtechnische Grundlagen zum szintigraphischen und intraoperativen Nachweis von Wächterlymphknoten der Prostata mit 99m Tc-Nanokolloid. Aachen: Shaker Verlag, 2005.

    Google Scholar 

  85. Suzuki T, Kurokawa K, Yamanaka H, et al. Lymphatic drainage of the prostate gland in canines. Prostate. 1992;21:279.

    Article  CAS  PubMed  Google Scholar 

  86. Aumüller G. Morphologie der normalen Prostata und experimentelle Modelle der Prostataforschung. In: Helpap B, Senge T, Vahlensieck W, editors. Die Prostata. Frankfurt: pmi; 1983:15.

    Google Scholar 

  87. Gallowitsch HJ. Lymphoscintigraphy and dosimetry. In: Munz DL, ed. The Sentinel Lymph Node Concept in Oncology. Facts and Fiction. Munich: W. Zuckschwerdt; 2001:57.

    Google Scholar 

  88. Uren RF, Howman-Giles RB, Thompson JF, et al. Mammary lymphoscintigraphy in breast cancer. J Nucl Med. 1995;36:1775.

    CAS  PubMed  Google Scholar 

  89. McMasters KM, Reintgen DS, Ross MI, et al. Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed? Ann Surg Oncol. 2001;8:192.

    Article  CAS  PubMed  Google Scholar 

  90. Brenot-Rossi I, Bastide C, Garcia S, et al. Limited pelvic lymphadenectomy using the sentinel lymph node procedure in patients with localized prostate carcinoma: a pilot study. Eur J Nucl Med Mol Imaging. 2005;32:635–640.

    Article  PubMed  Google Scholar 

  91. Wawroschek F, Vogt H, Weckermann D, et al. The sentinel lymph node concept in prostate cancer—first results of gamma probe-guided sentinel lymph node identification. Eur Urol. 1999;36:595–600.

    Article  CAS  PubMed  Google Scholar 

  92. Moul JW, Lewis DJ, Ross AA, et al. Immunohistologic detection of prostate cancer pelvic lymph node micrometastases: correlation to preoperative serum prostatespecific antigen. Urology. 1994;43:68–73.

    Article  CAS  PubMed  Google Scholar 

  93. Gomella LG, White JL, Mccue PA, et al. Screening for occult nodal metastasis in localized carcinoma of the prostate. J Urol. 1993;149:776–778.

    CAS  PubMed  Google Scholar 

  94. Wawroschek F, Wagner Th, Hamm M, et al. The influence of serial sections, immunohistochemistry, and extension of pelvic lymph node dissection on the lymph node status in clinically localized prostate cancer. Eur Urol. 2003;43:132–137.

    Article  PubMed  Google Scholar 

  95. Haas J, Wagner T, Wawroschek F, et al. Combined application of RT-PCR and immunohistochemistry on paraffin embedded sentinel lymph nodes of prostate cancer patients. Pathol Res Pract. 2005;200:763–770.

    Article  PubMed  Google Scholar 

  96. Lawrence WD. ADASP recommendations for processing and reporting of lymph node specimens submitted for evaluation of metastatic disease. Virchows Arch. 2001;439:601–603.

    CAS  PubMed  Google Scholar 

  97. Wengenmair H, Kopp J, Vogt H, et al. Sentinel lymph node diagnostic in prostate carcinoma. II. Biokinetics and dosimetry of 99mTc-nanocolloid after intraprostatic injection. Nucl Med. 2002;412:102–107.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology and Pediatric Urology, Hospital Oldenburg, Oldenburg, Germany

    Alexander Winter MD & Friedhelm Wawroschek MD

  2. Department of Nuclear Medicine, Klinikum Augsburg, Augsburg, Germany

    Harry Vogt MD

  3. Department of Urology, Klinikum Augsburg, Augsburg, Germany

    Dorothea Weckermann MD & Rolf Harzmann MD

Authors
  1. Alexander Winter MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Harry Vogt MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dorothea Weckermann MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rolf Harzmann MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Friedhelm Wawroschek MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Regional Center of Nuclear Medicine, University of Pisa Medical School, Pisa, Italy

    Giuliano Mariani MD

  2. John Wayne Cancer Institute, Saint John’s Health Center, Santa Monica, California, USA

    Armando E. Giuliano MD (Chief of Science and Medicine) (Chief of Science and Medicine)

  3. Nuclear Medicine Service, Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA

    H. William Strauss MD

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Winter, A., Vogt, H., Weckermann, D., Harzmann, R., Wawroschek, F. (2008). Sentinel Lymph Node Biopsy in Prostatic Cancer. In: Mariani, G., Giuliano, A.E., Strauss, H.W. (eds) Radioguided Surgery. Springer, New York, NY. https://doi.org/10.1007/978-0-387-38327-9_15

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-38327-9_15

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-33684-8

  • Online ISBN: 978-0-387-38327-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation